Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Predicting COVID-19 Severity with a Specific Nucleocapsid Antibody plus Disease Risk Factor Score

mSphere(2021)10.1128/msphere.00203-21Source: DataRank Database

Predicting COVID-19 Severity with a Specific Nucleocapsid Antibody plus Disease Risk Factor Score is a research paper published in mSphere (2021). On theSindex it has a DataRank of 0. It has been cited 25 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access25 citations

Download PDF

Cite:

Linked data & code

geo gen pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (13 grants)OA: goldTopics (78)IDs (PubMed, PMC)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (19)

Emily C. Sanders ORCID,Kristin Gabriel ORCID,Brian Miller ORCID,Hariny M. Isoda ORCID,Gabriela S. Salcedo ORCID

Live enrichment

PubMed:33910993 PMC:PMC8092137

HHS | NIH | National Cancer Institute

Grant: P30CA062203

HHS | National Institutes of Health

Grant: GM-69337

HHS | National Institutes of Health

Grant: TR001414

National Science Foundation

Grant: DGE-1839285

UC | Office of the President, University of California

Grant: Emergency COVID-19 Research Seed Funding

UC | University of California, Irvine

Grant: COVID-19 Basic Translational and Clinical Research Fund

NCATS NIH HHS

Grant: UL1 TR001414

NIGMS NIH HHS

Grant: T34 GM069337

National Institutes of Health

Grant: 2T34GM069337-11

MARC U*STAR at the University of California, Irvine

National Institutes of Health

Grant: 3P30CA062203-27S1

Clinical Trial Advancement and Development for Sarcomas

National Science Foundation

Grant: 1839285

Graduate Research Fellowship (GRFP)

National Institutes of Health

Grant: 3UL1TR001414-06S1

THE SEARCH FOR COVID-19 PREVENTION AND CURE: ADDRESSING THE CRITICAL ROLE OF INNATE/ADAPTIVE IMMUNITY BY INTEGRATING NOVEL INFORMATICS, TRANSLATIONAL TECHNOLOGIES, AND ONGOING CLINICAL TRIAL RESEARCH

Abbvie | Allergan Foundation

goldLicense: cc-by

publisherhttps://doi.org/10.1128/msphere.00203-21

publisherhttps://journals.asm.org/doi/pdf/10.1128/mSphere.00203-21

repositoryhttps://escholarship.org/content/qt7tb4d4gk/qt7tb4d4gk.pdf

repositoryhttps://doaj.org/article/0a8d4a6bdebb44fcb1bdd1d6db0f40b6

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8092137

Fields of Study

0303 health sciences03 medical and health sciences

MeSH Terms

HumansNucleocapsidPhosphoproteinsAntibodies, ViralEpitopesEnzyme-Linked Immunosorbent AssayPrognosisSeverity of Illness IndexRisk FactorsCell Surface Display TechniquesCOVID-19SARS-CoV-2Coronavirus Nucleocapsid Proteins

Keywords

Phage displayPrognosticEpitope mappingCoronavirusesSars-cov-2Prevention (rcdc)Cell Surface Display Techniques (mesh)Antibodies, ViralSeverity of Illness IndexEpitopesRisk FactorsViralHumans (mesh)3 Good Health and Well Being (sdg)COVID-19 (mesh)3107 Microbiology (for-2020)Biological SciencesCoronaviruses Disparities and At-Risk PopulationsPrognosisQR1-502Infection (hrcs-hc)Severity of Illness Index (mesh)Infectious DiseasesInfectionImmunology (science-metrix)BiotechnologyResearch ArticleEpitopes (mesh)ImmunologyNucleocapsid (mesh)6101107 Immunology (for)SARS-CoV-2 (mesh)Enzyme-Linked Immunosorbent AssayBiotechnology (rcdc)MicrobiologyEmerging Infectious Diseases (rcdc)AntibodiesViral (mesh)Risk Factors (mesh)616Enzyme-Linked Immunosorbent Assay (mesh)Coronavirus Nucleocapsid ProteinsHumansNucleocapsid3204 Immunology (for-2020)31 Biological Sciences (for-2020)Coronavirus Nucleocapsid Proteins (mesh)Biomedical and Clinical SciencesPrevention4.1 Discovery and preclinical testing of markers and technologies (hrcs-rac)Coronaviruses (rcdc)COVID-19Prognosis (mesh)Phosphoproteins4.1 Discovery and preclinical testing of markers and technologiesCoronaviruses Disparities and At-Risk Populations (rcdc)Phosphoproteins (mesh)Emerging Infectious DiseasesGood Health and Well BeingInfectious Diseases (rcdc)Microbiology (science-metrix)Cell Surface Display Techniques

Sustainable Development Goals

SDG 3: 3. Good health

Predicting COVID-19 Severity with a Specific Nucleocapsid Antibody plus Disease Risk Factor Score

FAIR Checklist

Authors (19)

Funding (13 grants)

Open Access

Topics

Annotations (Europe PMC)